Thioredoxin and its role in toxicology

Toxicological Sciences

Volumn 78, Issue 1, 2004, Pages 3-14

  Watson, Water H ^c   Yang, Xianmei ^a   Choi, Young Eun ^a   Jones, Dean P ^b   Kehrer, James P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Apoptosis; Glutathione; Redox; Thiols; Thioredoxin; Toxicology

Indexed keywords

DEOXYRIBONUCLEOTIDE; DISULFIDE; DITHIOL DERIVATIVE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; PEROXIDE; PEROXIREDOXIN; RIBONUCLEOTIDE; SULFENIC ACID DERIVATIVE; SULFOXIDE; THIOREDOXIN; TOXIC SUBSTANCE;

ALKYLATION; APOPTOSIS; CATALYSIS; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CYTOPLASM; DNA REPAIR; ENZYME ACTIVITY; HUMAN; MITOCHONDRION; MOLECULE; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION INITIATION;

ANIMALS; APOPTOSIS; GLUTATHIONE; HUMANS; OXIDATION-REDUCTION; THIOREDOXIN; TOXICOLOGY; TRANSCRIPTION FACTORS;

EID: 1642569593     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh050     Document Type: Review

References (132)

1. Aggarwal, B. B. (2000). Apoptosis and nuclear factor-κB: A tale of association and dissociation. Biochem. Pharmacol. 60, 1033-1039.
2. Allen, R. G. (1998). Oxidative stress and superoxide dismutase in development, aging, and gene regulation. Age 21, 47-76.
3. Anderson, M. M., Hazen, S. L., Hsu, F. F., and Heinecke, J. W. (1997). Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycoaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and α,β-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99, 424-432.
4. Andoh, T., Chock, P. B., and Chiueh, C. C. (2002). The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J. Biol. Chem. 277, 9655-9660.
5. Arner, E. S. J., and Holmgren, A. (2000). Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109.
6. Aslund, F., Berndt, K. D., and Holmgren, A. (1997). Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria. J. Biol. Chem. 272, 30780-30786.
7. Baker, A., Payne, C. M., Briehl, M. M., and Powis, G. (1997). Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res. 57, 5162-5167.
8. Balcewicz-Sablinska, M. K., Wollman, E. E., Gort, R., and Silberstein, D. S. (1991). Human eosinophil cytotoxicity-enhancing factor II: Multiple forms synthesized by U937 cells and their relationship to thioredoxin/adult T-cell leukemia-derived factor. J. Immunol. 147, 2170-2174.
9. Bertini, R., Howard, O. M., Dong, H. F., Oppenheim, J. J., Bizzarri, C., Sergi, R., Caselli, G., Pagliei, S., Romines, B., Wilshire, J. A., et al. (1999). Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med. 189, 1783-1789.
10. Biswal, S., Acquaah-Mensah, G., Datta, K., Wu, X. and Kehrer, J. P. (2002). Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications. Chem. Res. Toxicol. 15, 180-186.
11. Biswal, S., Maxwell, T., Rangasamy, T., and Kehrer, J. P. (2003). Modulation of benzo[a]pyrene-induced p53 DNA activity by acrolein. Carcinogenesis 24, 1401-1406.
12. Bodenstein, J., and Follmann, H. (1991) Characterization of two thioredoxins in pig heart, including a new mitochondrial protein. Zeitschrift für Naturforschung-Sec. C, Biosci. 46, 270-279.
13. Cantin, A. M., Larivee, P., and Begin, R. O. (1990). Extracellular glutathione suppresses human lung fibroblast proliferation. Am. J Resp. Cell Mol. Biol. 3, 79-85.
14. Casagrande, S., Bonetto, V., Fratelli, M., Gianazza, E., Eberini, I., Massignan, T., Salmona, M., Chang, G., Holmgren, A., and Ghezzi, P. (2002). Glutathionylation of human thioredoxin: A possible crosstalk between the glutathione and thioredoxin systems. Proc. Natl. Acad. Sci. U.S.A. 9, 9745-9749.
15. Chen, Y., Cai, J., Murphy, T. J., and Jones, D. P. (2002). Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 277, 33242-33248.
16. Cotgreave, I. A., and Gerdes, R. G. (1998). Recent trends in glutathione biochemistry - glutathione-protein interactions: A molecular link between oxidative stress and cell proliferation? Biochem. Biophys. Res. Commun. 242, 1-9.
17. Damdimopoulos, A. E., Miranda-Vizuete, A., Pelto-Huikko, M., Gustafsson, J.-Å., and Spyrou, G. (2002). Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J. Biol. Chem. 277, 33249-33257.
18. 2-terminal kinase-mediated redox-dependent degradation of IκB: Role of thioredoxin in NF-κB activation. J. Biol. Chem. 276, 4662-4670.
19. Das, K. C., Guo, X. L., and White, C. W. (1999). Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen. Am. J. Physiol. 276, L530-539.
20. Das, K. C, Lewis-Molock, Y., and White, C. W. (1997). Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am. J. Respir. Cell. Mol. Biol. 17, 713-726.
21. Davis, R. J. (1994). MAPKs: New JNK expands the group. Trends Biochem Sci. 19, 470-473.
22. Didier, C., Kerblat, I., Drouet, C., Favier, A., Beani, J. C., and Richard, M. J. (2001). Induction of thioredoxin by ultraviolet-A radiation prevents oxidative-mediated cell death in human skin fibroblasts. Free Radic. Biol. Med. 31, 585-598.
23. Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., and Talalay, P. (2002). Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 99, 11908-11913.
24. Ejima, K., Nanri, H., Toki, N., Kashimura, M. and Ikeda, M. (1999). Localization of thioredoxin reductase and thioredoxin in normal human placenta and their protective effect against oxidative stress. Placenta 20, 95-101.
25. Ema, M., Hirota, K., Mimura, J., Abe, H., Yodoi, J., Sogawa, K., Poellinger, L., and Fujii-Kuriyama, Y. (1999). Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: Their stabilization and redox-signal-induced interaction with CBP/p300. EMBO J. 18, 1905-1914.
26. Erve, J. C., Barofsky, E., Barofsky, D. F., Deinzer, M. L., and Reed, D. J. (1995). Alkylation of Escherichia coli thioredoxin by S-(2-chloroethyl)glutathione and identification of the adduct on the active site cysteine-32 by mass spectrometry. Chem. Res. Toxicol. 8, 934-941.
27. Fernando, M. R., Nanri, H., Yoshitake, S., Nagata-Kuno, K. and Minakami, S. (1992). Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells. Eur. J. Biochem. 209, 917-922.
28. Ferrari, D. M., and Soling, H. D. (1999). The protein disulphide-isomerase family: Unraveling a string of folds. Biochem. J. 339, 1-10.
29. Flohé, L, Brigelius-Flohé, R, Saliou, C, Traber, M. G., and Packer, L. (1997). Redox regulation of NF-κB activation. Free Radic. Biol. Med. 22, 1115-1126.
30. Forman, H. J., Torres, M., and Fukuto, J. (2002). Redox signaling. Mol. Cell. Biochem. 234/235, 49-62.
31. Freemerman, A. J., Gallegos, A., and Powis, G. (1999). Nuclear factor κB transactivation is increased but is not involved in the proliferative effects of thioredoxin overexpression in MCF-7 breast cancer cells. Cancer Res. 59, 4090-4094.
32. Freemerman, A. J., and Powis, G. (2000). A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells. Biochem. Biophys. Res. Commun. 274, 136-141.
33. Frischer, H., Kennedy, E. J., Chigurupati, R., and Sivarajan, M. (1993). Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia. J. Clin. Invest. 92, 2761-2767.
34. Gabbita, S. P., Robinson, K. A., Stewart, C. A., Foyd, R. A., and Hensley, K. (2000). Redox regulatory mechanisms of cellular signal transduction. Arch. Biochem. Biophys. 376, 1-13.
35. Gauntt, C. D., Ohira, A., Honda, O., Kigasawa, K., Fujimoto, T., Masutani, H., Yodoi, J., and Honda, Y. (1994). Mitochondrial induction of adult T-cell leukemia-derived factor (ADF/hTx) after oxidative stresses in retinal pigment epithelial cells. Investig. Ophthalmol. Visual Sci. 35, 2916-2923.
36. Geleziunas, R., Xu, W., Takeda, K., Ichijo, H., and Greene, W. C. (2001). HIV-1 Nef inhibits ASK1-dependent death signaling providing a potential mechanism for protecting the infected host cell. Nature 410, 834-838.
37. Ghilarducci, D. P., and Tjeerdema, R. S. (1995). Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 144, 95-146.
38. Gilbert, H. F. (1990). Molecular and cellular aspects of thiol-disulfide exchange. Adv. Enzymol. Relat. Areas Mol. Biol. 63, 69-172.
39. Gilbert, H. F. (1995). Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol. 251, 8-28.
40. Gius, D., Botero, A., Shah, S., and Curry, H. A. (1999). Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1. Toxicol. Lett. 106, 93-106.
41. Gon, Y., Sasada, T., Matsui, M., Hashimoto, S., Takagi, Y., Iwata, S., Wada, H., Horie, T., and Yodoi, J. (2001). Expression of thioredoxin in bleomycin-injured airway epithelium. Possible role of protection against bleomycin-induced epithelial injury. Life Sci. 68, 1877-1888.
42. Grippo, J. F., Holmgren, A., and Pratt, W. B. (1985). Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. J. Biol. Chem. 260, 93-97.
43. Grogan, T. M., Fenoglio-Prieser, C., Zeheb, R., Bellamy, W., Frutiger, Y., Vela, E., Stemmerman, G., Macdonald, J., Richter, L., Gallegos, A., and Powis, G. (2000). Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum. Pathol. 31, 475-481.
44. Haddad, J. J. (2002). Antioxidant and pro-oxidant mechanisms in the regulation of redox (y)-sensitive transcription factors. Cell. Signal. 14, 879-897.
45. Hainaut, P., and Mann, K. (2001). Zinc binding and redox control of p53 structure and function. Antiox. Redox Signal. 3, 611-623.
46. Hariharan, J., Hebbar, P., Ranie, J., Philomena, Sinha, A. M., and Datta, S. (1996). Alternative forms of the human thioredoxin mRNA: Identification and characterization. Gene 173, 265-270.
47. Hayashi, S., Hajiro-Nakanishi, K., Makino, Y., Eguchi, H., Yodoi, J., and Tanaka, H. (1997). Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res. 25, 4035-4040.
48. Hirano, M., Osada, S., Aoki, T., Hirai, S., Hosaka, M., Inoue, J., and Ohno, S. (1996). MEK kinase is involved in tumor necrosis factor α-induced NF-κB activation and degradation of IκB-α. J. Biol. Chem. 271, 13234-13238.
49. Hirota, K., Matsui, M., Iwata, S., Nishiyama, A., Mori, K., and Yodoi, J. (1997). AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. U.S.A. 94, 3633-3638.
50. Hirota, K., Murata, M., Sachi, Y., Nakamura, H., Takeuchi, J., Mori, K., and Yodoi J. (1999). Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-κB. J. Biol. Chem. 274, 27891-27897.
51. Holmgren, A. (2000). Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid. Redox. Signal 2, 811-820.
52. Holmgren, A., and Bjornstedt, M. (1995). Thioredoxin and thioredoxin reductase. Methods Enzymol. 252, 199-208.
53. Holmgren, A., and Fagerstedt, M. (1982). The in vivo distribution of oxidized and reduced thioredoxin in Escherichia coli. J. Biol. Chem. 257, 6926-6930.
54. Horton, N. D., Biswal, S. S., Corrigan, L. L., Bratta, J., and Kehrer, J. P. (1999). Acrolein causes IκB-independent decreases in NF-κB activation in human lung adenocarcinoma (A549) cells through the formation of p50 adducts. J. Biol. Chem. 274, 9200-9206.
55. Horton, N. D., Mamiya, B. M., and Kehrer, J. P. (1997). Relationships between cell density glutathione levels and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. Toxicology 122, 111-122.
56. Ichijo, H., Nishida, E., Irie, K., Dijke, P. T., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. (1997). Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94.
57. Jikimoto, T., Nishikubo, Y., Koshiba, M., Kanagawa, S., Morinobu, S., Morinobu, A., Saura, R., Mizuno, K., Kondo, S., Toyokuni, S., Nakamura, H., Yodoi, J., and Kumagai S. (2002). Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol. Immunol. 38, 765-772.
58. Kehrer, J. P., and Biswal, S. S. (2000). The molecular effects of acrolein. Toxicol. Sci. 57, 6-15.
59. Kim, Y.-C., Yamaguchi, Y., Kondo, N., Masutani, H., and Yodoi, J. (2003). Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene 22, 1860-1865.
60. Kumar, S., Rabson, A. B., and Gelinas, C. (1992). The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol. Cell. Biol. 12, 3094-3106.
61. Lane, D. P. (1992). p53, Guardian of the genome. Nature 358, 15-16.
62. Lee, K., Murakawa, M., Takahashi, S., Tsubuki, S., Kawashima, S., Sakamaki, K., and Yonehara, S. (1998). Purification, molecular cloning, and characterization of TRP32, a novel thioredoxin-related mammalian protein of 32 kDa. J. Biol. Chem. 273, 19160-19166.
63. Li, L., Hamilton, R. F., Jr., and Holian, A. (1999). Effect of acrolein on human alveolar macrophage NF-κB activity. Am. J. Physiol. 277, L550-557.
64. Liu, Y., and Min, W. (2002). Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ. Res. 90, 1259-1266.
65. Lowther, W. T., Brot, N., Weissbach, H., Honek, J. F., and Matthews, B. W. (2000). Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase. Proc. Natl. Acad. Sci. U.S.A. 97, 6463-6468.
66. Lundstrom, J., and Holmgren, A. (1993). Determination of the reduction-oxidation potential of the thioredoxin-like domains of protein disulfide-isomerase from the equilibrium with glutathione and thioredoxin. Biochemistry 32, 6649-6655.
67. Ly, J. D., Grubb, D. R., and Lawen, A. (2003). The mitochondrial membrane potential (ΔΨm) in apoptosis: An update. Apoptosis 8, 115-128.
68. Makino, Y., Yoshikawa, N., Okamoto, K., Hirota, K., Yodoi, J., Makino, I., and Tanaka, H. (1999). Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J. Biol. Chem. 274, 3182-3188.
69. Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama, T., Yodoi, J., and Taketa, M. M. (1996). Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Develop. Biol. 178, 179-185.
70. Meyer, C. F., Wang, X., Chang, C., Templeton, D., and Tan, T. H. (1996). Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating κB enhancer activation. J. Biol. Chem. 271, 8971-8976.
71. Miranda-Vizuete, A., Gustafsson, J., and Spyrou, G. (1998). Molecular cloning and expression of a cDNA encoding a human thioredoxin-like protein. Biochem. Biophys. Res. Commun. 243, 284-288.
72. Nakamura, H., Herzenberg, L. A., Bai, J., Araya, S., Kondo, N., Nishinaka, Y., Herzenberg, L. A., and Yodoi, J. (2001). Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc. Natl. Acad. Sci. U.S.A. 98, 15143-15148.
73. Nguyen, T., Huang, H. C., and Pickett, C. B. (2000). Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by Mafk. J. Biol. Chem. 275, 15466-15473.
74. Nishiyama, A., Masutani, H., Nakamura, H., Nishinaka, Y., and Yodoi, J. (2001). Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life 52, 29-33.
75. Nkabyo, Y. S., Ziegler, T. R., Gu, L. H., Watson, W. H., and Jones, D. P. (2002). Glutathione and thioredoxin redox during differentiation in human colonic epithelial (Caco-2) cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G1352-1359.
76. Nonn, L., Williams, R. R., Erickson, R. P., and Powis, G. (2003). The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23, 916-922.
77. Nordberg, J., and Arner, E. S. J. (2001). Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31, 1287-1312.
78. Ott, M., Robertson, J. D., Gogvadze, V., Zhivotovsky, B., and Orrenius, S. (2002). Cytochrome c release from mitochondria proceeds by a two-step process. Proc. Natl. Acad. Sci. U.S.A. 99, 1259-1263.
79. Park, J., and Churchich, J. E. (1992). Interaction of thioredoxin with oxidized aminobutyrate aminotransferase. Evidence for the formation of a covalent intermediate. FEBS Lett. 310, 1-4.
80. Pedrajas, J. R., Miranda-Vizuete, A., Javanmardy, N., Gustafsson, J. A., and Spyrou, G. (2000). Mitochondria of Saccharomyces cerevisiae contain one conserved cysteine-type peroxiredoxin with thioredoxin peroxidase activity. J. Biol. Chem. 275, 16296-16301.
81. Pekkari, K., Gurunath, R., Arner, E. S., and Holmgen, A. (2000). Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma. J. Biol. Chem. 275, 37474-37480.
82. Pinkus, R., Bergelson, S., and Daniel, V. (1993). Phenobarbital induction of AP-1-binding activity mediates activation of glutathione S-transferase and quinone reductase gene expression. Biochem. J. 290, 637-640.
83. Powis, G., Gasdaska, J. R., and Baker, A. (1997). Redox signaling and the control of cell growth and death. Adv. Pharmacol. 38, 329-359.
84. Powis, G., and Montfort, W. R. (2001). Properties and biological activities of thioredoxins. Annu. Rev. Pharmacol. Toxicol. 41, 261-295.
85. Powis, G., Mustacich, D., and Coon, A. (2000). The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29, 312-322.
86. Qin, J., Clore, G. M., Kennedy, W. M., Huth, J. R., and Gronenborn, A. M. (1995). Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF-κB. Structure 3, 289-297.
87. Ramu, K., Perry, C. S., Ahmed, T., Pakenham, G., and Kehrer, J. P. (1996). Studies on the basis for the toxicity of acrolein mercapturates. Toxicol. Appl. Pharmacol. 140, 487-498.
88. Reddy, P. G., Bhuyan, D. K., and Bhuyan, K. C. (1999). Lens-specific regulation of the thioredoxin-1 gene, but not thioredoxin-2, upon in vivo photochemical oxidative stress in the Emory mouse. Biochem. Biophys. Res. Commun. 265, 345-349.
89. Ren, X., Bjornstedt, M., Shen, B., Ericson, M. L., and Holmgren, A. (1993). Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. Biochemistry 32, 9701-9708.
90. Rhee, S. G., Kang, S. W., Chang, T.-S., Jeong, W., and Kim, K. (2001). Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52, 35-41.
91. Rosen, A., Lundman, P., Carlsson, M., Bhavani, K., Srinivasa, B. R., Kjellstrom, G., Nilsson, K. and Holmgren, A. (1995). A CD4+ T-cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. Int. Immunol. 7, 625-633.
92. Rubartelli, A., Bajetto, A., Allavena, G., Wollman, E., and Sitia, R. (1992). Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267, 24161-24164.
93. Rubartelli, A., Bonifaci, N., and Sitia, R. (1995). High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res. 55, 675-680.
94. Rupec, R. A., and Baeurle, P. A. (1995). The genomic response of tumor cells to hypoxia and reoxygenation differential activation of transcription factors AP-1 and NF-κB. Eur. J. Biochem. 234, 632-640.
95. Rybnikova, E., Damdimopoulos, A. E., Gustafsson, J. Å., Spyrou, G., and Pelto-Huikko, M. (2000). Expression of novel antioxidant thioredoxin-2 in the rat brain. Eur. J. Neurosci. 12, 1669-1678.
96. Saitoh, M., Nishitoh, H., Fujii, H., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., and Ichijo, H. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK1). EMBO J. 17, 2596-2606.
97. Sasada, T., Iwata, S., Sato, N., Kitaoka, Y., Hirota, K., Nakamura, K., Nishiyama, A., Taniguchi, Y., Takabayashi, A., and Yodoi, J. (1996). Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): Protective effect of human thioredoxin against CDDP-induced cytotoxicity. J. Clin. Invest. 97, 2268-2276.
98. Shaulian, E., and Karin, M. (2002). AP-1 as a regulator of cell life and death. Nature Cell Biol. 4, E131-136.
99. Sheikh, M.S., and Fornace, A. J., Jr. (2000). Role of p53 family members in apoptosis. J. Cell. Physiol. 182, 171-181.
100. Shibata, T., Yamada, T., Ishii, T., Kumazawa, S., Nakamura, H., Masutani, H., Yodoi, J., and Uchida, K. (2003). Thioredoxin as a molecular target of cyclopentenone prostaglandins. J. Biol. Chem. 278, 26046-26054.
101. Shioji, K., Kishimoto, C., Nakamura, H., Masutani, H., Yuan, Z., Oka, S-i, and Yodoi, J. (2002). Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 106, 1403-1409.
102. Sies, H. (1999). Glutathione and its role in cellular functions. Free Radic. Biol. Med. 27, 916-921.
103. Smith, C. V., Jones, D. P., Guenthner, T. M., Lash, L. H., and Lauterburg, B. H. (1996). Compartmentation of glutathione: Implications for the study of toxicity and disease. Tox. Appl. Pharmacol. 140, 1-12.
104. Soderberg, A., Sahaf, B., and Rosen, A. (2000). Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: Presence in human plasma. Cancer Res. 60, 2281-2289.
105. Spyrou, G., Enmark, E., Miranda-Vizuete, A., and Gustafsson, J. (1997). Cloning and expression of a novel mammalian thioredoxin. J. Biol. Chem. 272, 2936-2941.
106. Spyrou, G., and Holmgren, A. (1996). Deoxyribonucleoside triphosphate pools and growth of glutathione-depleted 3T6 mouse fibroblasts. Biochem. Biophys. Res. Commun. 220, 42-46.
107. Srivastava, S., Watowich, S. J., Petrash, J. M., Srivastava, S. K., and Bhatnagar, A. (1999). Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry 38, 42-54.
108. Stewart, Z. A., and Pietenpol, J. A. (2001). p53-Signaling and cell-cycle checkpoints. Chem. Res. Toxicol. 14, 243-263.
109. Sumbayev, V. V. (2003). S-nitrosylation of thioredoxin mediates activation of apoptosis signal-regulating kinase 1. Arch. Biochem. Biophys. 415, 133-136.
110. Sumida, Y., Nakashima, T., Yoh, T., Furutani, M., Hirohama, A., Kakisaka, Y., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Okanoue, T., et al. (2003). Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J. Hepatol. 38, 32-38.
111. Sumida, Y., Nakashima, T., Yoh, T., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Sakamoto, Y., Okanoue, T., Kashima, K., Nakamura, H., et al. (2000). Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis-C virus infection. J. Hepatol. 33, 616-622.
112. Takagi, Y., Horikawa, F., Nozaki, K., Sugino, T., Hashimoto, N., and Yodoi, J. (1998). Expression and distribution of redox regulatory protein, thioredoxin, during transient focal brain ischemia in the rat. Neurosci. Lett. 251, 25-28.
113. Tanaka, T., Hosoi, F., Yamaguchi-Iwai, Y., Nakamura, H., Masutani, H., Ueda, S., Nishiyama, A., Takeda, S., Wada, H., Spyrou, G., and Yodoi, J. (2002). Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 21, 1695-1703.
114. Tanaka, T., Nakamura, H., Nishiyama, A., Hosoi, F., Masutani, H., Wada, H. and Yodoi, J. (2000). Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging. Free Radic. Res. 33, 851-855.
115. Tanaka, T., Nishiyama, Y., Okada, K., Hirota, K., Matsui, M., Yodoi, J., Hiai, H., and Toyokuni, S. (1997). Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: Independence of tubular necrosis and sulfhydryl depletion. Lab. Invest. 77, 145-155.
116. Tanudji, M., Hevi, S., and Chuck, S. L. (2003). The nonclassic secretion of thioredoxin is not sensitive to redox state. Am. J. Physiol. Cell. Physiol. 284, C1272-1279.
117. Tobiume, K., Inage, T., Takeda, K., Enomoto, S., Miyazono, K., and Ichijo, H. (1997). Molecular cloning and characterization of the mouse apoptosis signal-regulating kinase 1. Biochem. Biophys. Res. Commun. 239, 905-910.
118. Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K.-I., Takeda, K., Minowa, O., Miyazono, K., Noda, T., and Ichijo, H. (2001). ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2, 222-228.
119. Toledano, M. B., Ghosh, F., Trinh, D., and Leonard. W. J. (1993). N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-κB p50 and p65. Mol. Cell. Biol. 13, 852-860.
120. Trotter, E. W., and Grant, C. M. (2003). Nonreciprocal regulation of the redox state of the glutathione-glutaredoxin and thioredoxin systems. EMBO Reports 4, 184-188.
121. Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattori, N., Mizuno, Y., Suzuki, D., Miyata, T., Noguchi, N., Niki, E., and Osawa, T. (1998). Protein-bound acrolein: Potential markers for oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 95, 4882-4887.
122. Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara, S., Takabayashi, A., Yamaoka, Y., and Yodoi, J. (1998). Redox regulation of caspase-3-like protease activity: Regulatory roles of thioredoxin and cytochrome c. J. Immunol. 161, 6689-6695.
123. Ueno, M., Masutani, H., Arai, R. J., Yamauchi, A., Hirota, K., Sakai, T., Inamoto, T., Yamaoka, Y., Yodoi, J., and Nikaido, T. (1999). Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274, 35809-35815.
124. Wang, P. F., Veine, D. M., Ahn, S. H., and Williams, C. H., Jr. (1996). A stable mixed disulfide between thioredoxin reductase and its substrate, thioredoxin: Preparation and characterization. Biochemistry 35, 4812-4819.
125. Wang, X. (2001). The expanding role of mitochondria in apoptosis. Genes & Development 15, 2922-2933.
126. Waskiewicz, A. J., and Cooper, J. A. (1995). Mitogen- and stress-response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell. Biol. 7, 798-805.
127. Watson, W. H., and Jones, D. P. (2003). Oxidation of nuclear thioredoxin during oxidative stress. FEBS Lett. 543, 144-147.
128. Watson, W. H., Pohl, J., Montfort, W. R., Stuchlik, O., Powis, G., and Jones, D. P. (2003). Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J. Biol. Chem. 278, 33408-33415.
129. Wei, S. J., Botero, A., Hirota, K., Bradbury, C. M., Markovina, S., Laszlo, A., Spitz, D. R., Goswami, P. C., Yodoi, J., and Gius, D. (2000). Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res. 60, 6688-6695.
130. Widmann, C., Gibson, S., Jarpe, M. B., and Johnson, G. L. (1999). Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol. Rev. 79, 143-180.
131. Wiesel, P., Foster, L. C., Pellacani, A., Layne, M. D., Hsieh, C. M., Huggins, G. S., Strauss, P., Yet, S. F., and Perrella, M. A. (2000). Thioredoxin facilitates the induction of heme oxygenase-1 in response to inflammatory mediators. J. Biol. Chem. 275, 24840-24846.
132. Yamada, Y., Nakamura, H., Adachi, T., Sannohe, S., Oyamada, H., Kayaba, H., Yodoi, J., and Chihara, J. (2003). Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. Immunol. Lett. 86, 199-205.